Join multiple myeloma specialist, Dr. Douglas Sborov, as he reviews the open clinical trials for myeloma patients at the renowned Huntsman Institute in Salt Lake City, Utah. Clinical trials are a way to access leading-edge myeloma treatments. Myeloma patients should always consider clinical trials as one of their treatment options.
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.
Dr. Douglas Sborov is an Assistant Professor in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah School of Medicine. He was born and raised in Minnesota, completed his undergraduate education with a Bachelor of Science at the University of Wisconsin-Madison, later completed medical school through the American University of the Caribbean, and spent 3 years in Salt Lake City for his internal medicine residency. After almost 5 years in Columbus, OH, completing hematology, oncology, and bone marrow transplantation fellowships and joining the Division of Hematology as a Clinical Instructor, he and his family were drawn back to the beauty of the Wasatch Front where he joined the Division of Hematology to continue his career as a clinical trialist focused on the treatment of patients with hematologic malignancies. Dr. Sborov is the Director of the Multiple Myeloma Program, an Associate Member of the Huntsman Cancer Institute Experimental Therapeutics Program, Physician Leader of the Multiple Myeloma/Bone Marrow Transplant arm of the HCI Clinical Trials Office (CTO), and an active member of the HCI Protocol Review and Monitoring Committee.
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
+1 800 709 1113